MICROBIOTA PATOGÊNICA E RESISTÊNCIA AOS ANTIMICROBIANOS EM INDIVÍDUOS COM INFECÇÃO DO TRATO URINÁRIO
Visualizações: 50DOI:
https://doi.org/10.56579/rei.v6i3.1032Keywords:
Infecções Urinárias, Bacteriúria, Resistência Microbiana a Medicamentos, Farmacorresistência BacterianaAbstract
Objective: To evaluate the incidence of urinary tract infection (UTI), isolated bacterial agents and antimicrobial resistance in a non-hospitalized population. Methods: Cross-sectional study with urine culture data from individuals seen in a clinical laboratory between 2013 and 2022. Results: 20,011 individuals who underwent the test during the period were included, of which 7.17% obtained results indicative of infection of the urinary tract. Among them, 91.6% were women. Escherichia coli was responsible for 78.2% of urine cultures indicative of UTI. Other Gram-negatives accounted for 12.6%. Gram-positive cocci infected the urinary tract of 9.3% of the individuals studied, with emphasis on Enterococcus spp. and Streptococcus saprophyticus. The antimicrobial resistance profile, by antibiotic class, considering all bacterial genera showed: 80% resistance to tetracyclines, 40% to penicillins, 37% to macrolides, 15% to glycopeptides, 12% to quinolones, 6% to cephalosporins , 4% to aminoglycosides and 2% to carbapenems. Conclusion: Our findings show a profile of UTI incidence, bacterial flora and antimicrobial resistance profile similar to those described in the literature.
Downloads
References
ABRAMS, P. et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourology and Urodynamics, v. 29, n. 1, p. 213–240, 2010.
CROXEN, M. A.; FINLAY, B. B. Molecular mechanisms of Escherichia coli pathogenicity. Nature Reviews. Microbiology, v. 8, n. 1, p. 26–38, jan. 2010.
DAVID, R. D.; DEBLIEUX, P. M. C.; PRESS, R. Rational antibiotic treatment of outpatient genitourinary infections in a changing environment. The American Journal of Medicine, v. 118 Suppl 7A, p. 7S-13S, jul. 2005.
DEKKER, J.; FRANK, K. Salmonella, Shigella, and Yersinia. Clinics in laboratory medicine, v. 35, n. 2, p. 225–246, jun. 2015.
ELHOSHI, M. et al. A correlation study between virulence factors and multidrug resistance among clinical isolates of Proteus mirabilis. Braz J Microbiol. v. 54, n. 3, p. 1387-1397, ago. 2023.
FLORES-MIRELES, A. L. et al. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature Reviews. Microbiology, v. 13, n. 5, p. 269–284, maio 2015.
FRIDKIN, S. K. et al. Methicillin-resistant Staphylococcus aureus disease in three communities.” The New England journal of medicine, vol. 352, n. 14, 7 abr. 2005.
HAGAN, E. C. et al. Escherichia coli global gene expression in urine from women with urinary tract infection. PLoS pathogens, v. 6, n. 11, p. e1001187, 11 nov. 2010.
HSU, D.; MELZER, M. Strategy to reduce E. coli bacteraemia based on cohort data from a London teaching hospital. Postgraduate Medical Journal, v. 94, n. 1110, p. 212–215, abr. 2018.
HUANG, L. et al. Urinary Tract Infection Etiological Profiles and Antibiotic Resistance Patterns Varied Among Different Age Categories: A Retrospective Study From a Tertiary General Hospital During a 12-Year Period. Frontiers in Microbiology, v. 12, p. 813145, 2021.
KLEIN, R. D.; HULTGREN, S. J. Urinary tract infections: microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nature Reviews. Microbiology, v. 18, n. 4, p. 211–226, abr. 2020.
KOT, B. Antibiotic Resistance Among Uropathogenic Escherichia coli. Polish journal of microbiology, v. 68, n. 4, p. 403–415, dez. 2019.
OLIVEIRA, L. L. P. de et al. INFECÇÕES DO TRATO URINÁRIO: UMA ABORDAGEM CLÍNICO-TERAPÊUTICA. Facit Business and Technology Journal, v. 1, n. 27, 29 jun. 2021.
OMLI, R. et al. Pad per day usage, urinary incontinence and urinary tract infections in nursing home residents. Age and Ageing, v. 39, n. 5, p. 549–554, set. 2010.
OTTO, M. Community-associated MRSA: what makes them special? International journal of medical microbiology: IJMM, v. 303, n. 6–7, p. 324–330, ago. 2013.
PELEG, A. Y.; HOOPER, D. C. Hospital-acquired infections due to gram-negative bacteria. The New England Journal of Medicine, v. 362, n. 19, p. 1804–1813, mai. 2010.
SCHAFFER, J. N.; PEARSON, M. M. Proteus mirabilis and Urinary Tract Infections. Microbiology Spectrum, v. 3, n. 5, out. 2015.
SEYMOUR, C. W. et al. Time to Treatment and Mortality during Mandated Emergency Care for Sepsis. The New England Journal of Medicine, v. 376, n. 23, p. 2235–2244, 8 jun. 2017.
SILVA, R. DE A.; SOUSA, T. A. DE; VITORINO, K. DE A. Infecção do Trato Urinário na Gestação: Diagnóstico e Tratamento. Revista Científica da Faculdade de Educação e Meio Ambiente, v. 10, n. 1, p. 71–80, 26 jul. 2019.
SOUSA, M. F. et al. Microbiological and microstructural analysis of indwelling bladder catheters and urinary tract infection prevention. Revista da Escola de Enfermagem da USP, v. 56, p. e20210552, 2022.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Interdisciplinary Studies Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
The Journal of Interdisciplinary Studies adopts the Creative Commons Attribution 4.0 International License (CC BY 4.0), which allows for sharing and adapting the work, including for commercial purposes, provided proper attribution is given and the original publication in this journal is acknowledged.
